L
L-nutra
Nutri-technology company, spearheading longevity science nutrition programs
About L-nutra
L-Nutra is a health technology startup that operates in the nutritech sector, focusing on the development of natural, plant-based solutions aimed at optimizing healthspan, curing diseases, and extending life. The company's mission is to transform the current sick care system into a proactive health care model, emphasizing the role of food and lifestyle in maintaining health and longevity.
L-Nutra's primary offering is its Fasting Mimicking Technology platform, which is designed to trigger cellular rejuvenation and support healthy aging. This technology is based on scientific discoveries that suggest controlled fasting can have significant health benefits. In essence, the company's products aim to mimic the effects of fasting, thereby helping individuals reach their full health potential.
The company's business model is centered on the development and sale of these plant-based solutions, which are designed to be consumed continually. L-Nutra also leverages artificial intelligence technology and collaborates with health professionals to provide lifestyle education, further enhancing the value of its offerings.
The company's target market is broad, encompassing anyone interested in improving their health and longevity. This includes individuals seeking to prevent or cure diseases, as well as those simply looking to optimize their overall health.
In terms of revenue generation, L-Nutra makes money through the sale of its plant-based solutions and potentially through partnerships with health professionals and organizations.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Los Angeles, United States
- Employees
- 70
- Open positions
- None listed
- Dealroom signal
- 46.1/100
- Industry
- Health, Food
- Sub-industry
- Health Platform, Innovative Food
- Sector
- Health Tech & Medtech, Weight Management, Nutrition, Metabolism, Hard Tech, Longevity
- Technology
- Artificial Intelligence
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Nov 2023 | $47M | $188M | Stephane Bancel · Brentwood Associates | ↗ |
| SERIES C✓Equity / VC | May 2023 | $0 | — | Portfolia Funds | — |
Growth signals
Latest recorded traffic for L-nutra is 4K monthly website visits, down 37.5% over the last three months. L-nutra's team grew 11.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Hedgewood
Series B and later3 investors entered at this stage
Brentwood Associates
Portfolia Funds- SBStephane Bancel
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about L-nutra on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See L-nutra’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







